Sandoz Group Future Growth
Future criteria checks 4/6
Sandoz Group is forecast to grow earnings and revenue by 34% and 6% per annum respectively. EPS is expected to grow by 33.9% per annum. Return on equity is forecast to be 14.1% in 3 years.
Key information
34.0%
Earnings growth rate
33.9%
EPS growth rate
| Pharmaceuticals earnings growth | 18.9% |
| Revenue growth rate | 6.0% |
| Future return on equity | 14.1% |
| Analyst coverage | Good |
| Last updated | 11 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 11,835 | 1,257 | 1,230 | 1,453 | 11 |
| 12/31/2025 | 11,079 | 998 | 1,040 | 1,256 | 13 |
| 12/31/2024 | 10,353 | 637 | 645 | 825 | 13 |
| 6/30/2024 | 10,111 | -8 | -133 | 506 | N/A |
| 3/31/2024 | 10,045 | 35 | -195 | 434 | N/A |
| 12/31/2023 | 9,979 | 77 | -258 | 362 | N/A |
| 9/30/2023 | 9,770 | 345 | 136 | 664 | N/A |
| 6/30/2023 | 9,561 | 613 | 530 | 966 | N/A |
| 3/31/2023 | 9,434 | 731 | 679 | 1,095 | N/A |
| 12/31/2022 | 9,306 | 848 | 828 | 1,223 | N/A |
| 12/31/2021 | 9,678 | 908 | 1,000 | 1,354 | N/A |
| 12/31/2020 | 9,658 | 462 | 813 | 1,098 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: D8Y0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: D8Y0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: D8Y0 is expected to become profitable in the next 3 years.
Revenue vs Market: D8Y0's revenue (6% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: D8Y0's revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: D8Y0's Return on Equity is forecast to be low in 3 years time (14.1%).